Literature DB >> 17728315

Biological monitoring of TDI-derived amines in polyurethane foam production.

Shaun Austin1.   

Abstract

BACKGROUND: Toluene diisocyanate (TDI) is used in industry in the production of flexible polyurethane foam, commonly a mixture of the 2,4- and 2,6- isomers. The production process may lead to exposure to diisocyanates which are associated with respiratory disease. A method has been available for the determination of TDI biomarkers in urine for some years. AIMS: To explore the usefulness of urinary toluenediamine (uTDA) in assessing whether dermal absorption of diisocyanates makes a significant contribution to a worker's total exposure.
METHODS: Twenty-six workers took part in the study. Thirteen workers whose duties brought them into physical contact with uncured polyurethane foam during their shift (handlers) were compared to a control group of 13 workers in the same block plant environment had no physical contact with uncured foam on the day that sampling took place (non-handlers). Creatinine-adjusted uTDA levels in the two groups were compared across a work shift.
RESULTS: Both groups of workers were exposed to similar levels of airborne TDI. Ten handlers were found to have TDA in post-shift urine samples above detection limits compared with two non-handlers (P < 0.05). No clear relationship was found between the level of airborne TDI exposure and post-shift uTDA.
CONCLUSIONS: uTDA provides a useful indication of the contribution which skin absorption makes to total TDI exposure. The results suggest that skin protection when handling uncured polyurethane foam may not receive sufficient consideration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728315     DOI: 10.1093/occmed/kqm085

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  8 in total

1.  Urine 1,6-hexamethylene diamine (HDA) levels among workers exposed to 1,6-hexamethylene diisocyanate (HDI).

Authors:  Linda G T Gaines; Kenneth W Fent; Sheila L Flack; Jennifer M Thomasen; Louise M Ball; David B Richardson; Kai Ding; Stephen G Whittaker; Leena A Nylander-French
Journal:  Ann Occup Hyg       Date:  2010-06-07

2.  Factors affecting variability in the urinary biomarker 1,6-hexamethylene diamine in workers exposed to 1,6-hexamethylene diisocyanate.

Authors:  Linda G T Gaines; Kenneth W Fent; Sheila L Flack; Jennifer M Thomasen; Stephen G Whittaker; Leena A Nylander-French
Journal:  J Environ Monit       Date:  2010-10-26

3.  Response to Goodman et al.

Authors:  Lynne E Pinkerton; James H Yiin; Robert D Daniels; Kenneth W Fent
Journal:  Am J Ind Med       Date:  2017-02       Impact factor: 2.214

4.  Mortality among workers exposed to toluene diisocyanate in the US polyurethane foam industry: Update and exposure-response analyses.

Authors:  Lynne E Pinkerton; James H Yiin; Robert D Daniels; Kenneth W Fent
Journal:  Am J Ind Med       Date:  2016-06-27       Impact factor: 2.214

5.  Quantitative plasma biomarker analysis in HDI exposure assessment.

Authors:  Sheila L Flack; Kenneth W Fent; Linda G Trelles Gaines; Jennifer M Thomasen; Steve Whittaker; Louise M Ball; Leena A Nylander-French
Journal:  Ann Occup Hyg       Date:  2009-10-04

6.  Biomonitoring for Occupational Exposure to Diisocyanates: A Systematic Review.

Authors:  Bernice Scholten; Laura Kenny; Radu-Corneliu Duca; Anjoeka Pronk; Tiina Santonen; Karen S Galea; Miranda Loh; Katriina Huumonen; Anne Sleeuwenhoek; Matteo Creta; Lode Godderis; Kate Jones
Journal:  Ann Work Expo Health       Date:  2020-07-01       Impact factor: 2.179

7.  Statistical Comparison of Carcinogenic Effects and Dose-Response Relationships in Rats and Mice for 2,4-Toluene Diamine to those Ascribed to Toluene Diisocyanate.

Authors:  Robert L Sielken; Robert S Bretzlaff; Ciriaco Valdez-Flores; Ralph Parod
Journal:  Hum Ecol Risk Assess       Date:  2012-11-06       Impact factor: 5.190

8.  Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies.

Authors:  Robert M Park
Journal:  Saf Health Work       Date:  2020-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.